[ET Net News Agency, 11 March 2024] KEYMED BIO-B (02162) rose 10.6% to HK$33.85,
breaking above the 20-D SMA of HK$32.8.
It hits an intra-day high of HK$33.85, and an intra-day low of HK$30.9. The total shares
traded was 1.19 million, with a value of HK$39.32m. The active buy/sell ratio is 67:33,
with net buying turnover of HK$12.72m. HSBC SEC BRO (ASIA) accounts for greatest net
responsive buying turnover of HK$291,400, with volume weighted average price of HK$32.908.
CHINA INV INFO accounts for greatest net responsive selling turnover of HK$4.46m, with
volume weighted average price of HK$32.997. The stock has risen a combined 11.9% over the
past 2 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 33.850 % Chg +10.62%
High 33.850 Low 30.900
Shares Tr 1.19m Turnover 39.32m
10-D SMA 33.590 %H.V 67.410
20-D SMA 32.800 VWAP 32.941
50-D SMA 35.447 RSI14 50.450
----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 67:33, with net buying
turnover of HK$12.72m, rising a combined 11.9% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
KEYMED BIO-B (02162) 33.85 +10.62
GENSCRIPT BIO (01548) 15.16 +5.42
INNOVENT BIO (01801) 39.45 +0.25
JXR (01951) 2.51 +3.72
EVEREST MED-B (01952) 29.30 +2.99
LAEKNA-B (02105) 7.20 -2.83
WUXI BIO (02269) 17.28 -0.92
BEIGENE (06160) 97.45 +0.36
SCICLONE PHARMA (06600) 13.60 -4.23
AKESO (09926) 47.30 +0.11
-----------------------------------------------
(ed)